By Taylor Mixides (Drug Target Review)2024-03-15T11:45:58
We had the privilege of talking to Dr Petra Dieterich, Senior Vice President at Abzena, about her highly successful career. After gaining her D.Phil in synthetic organic chemistry and an MBA from Imperial College London, she has held various leadership positions and has worked in the CRO and CDMO environment, ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-08-28T10:00:24Z
2023-07-04T10:05:58
Sponsored by Revvity
2025-05-14T14:30:00
Sponsored by Abzena
2024-01-26T13:22:42
Sponsored by bit.bio
2024-03-08T10:00:25
Sponsored by Molecular Devices
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud